# The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

> **NCT01260584** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 110 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01260584
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260584, "The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01260584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*